NFE2L2 and neoplasm: On the contrary, C57BL/6 mice injected subcutaneously with Nrf2 knockdown Hepa1–6 cells showed a decrease in tumor size and diminished NQO1 and HO-1 mRNA expression after sorafenib administration when compared to Nrf2-shRNA control mice [309].